• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期帕金森病中的 5-羟色胺能神经传递:一项评估该疾病中抑郁影响的初步研究。

Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.

机构信息

Department of Clinical Psychology, Humboldt University, Berlin, Germany.

出版信息

World J Biol Psychiatry. 2010 Sep;11(6):781-7. doi: 10.3109/15622975.2010.491127.

DOI:10.3109/15622975.2010.491127
PMID:20586535
Abstract

OBJECTIVES

Depression, a disease usually accompanied by a serotonergic deficit, has been observed in about 40% of patients suffering from Parkinson's disease (PD). Thus, a serotonergic dysfunction in PD can be assumed. We aimed to investigate the interaction between serotonergic (5-HT) and dopaminergic activity in early PD. We hypothesized a serotonergic as well as a dopaminergic deficit in PD patients. We also assumed a correlation between these neurotransmitters indicating a relationship between dopaminergic and serotonergic function in PD.

METHODS

Nine unmedicated PD patients before and 12 weeks after L-dopa treatment and nine healthy subjects were examined using the loudness dependence of auditory evoked potentials (LDAEP), a promising indicator of central serotonergic function. Dopaminergic transporters (DAT) were collected using (123)I-FP-CIT and single photon emission computer tomography (SPECT). LDAEP values were correlated with (123)I-FP-CIT SPECT data.

RESULTS

A significant difference between LDAEP of controls and patients (P= 0.05) suggested lower serotonergic activity in PD. Twelve weeks after initiation of L-dopa treatment this difference was lost between patients and controls (P= 0.20). There was a trend towards a correlation between LDAEP and DAT (r= 0.65; P = 0.057) of the unmedicated patients, suggesting a low serotonergic activity may be related to a dopamine deficit in PD.

CONCLUSIONS

Our results support the hypothesis that serotonergic neurotransmission is decreased in untreated PD and suggest that a low serotonergic activity may be related to the dopamine pathology in PD. This could be related to the high prevalence of depression in PD.

摘要

目的

抑郁症通常伴随着 5-羟色胺(5-HT)缺乏,约 40%的帕金森病(PD)患者患有抑郁症。因此,可假设 PD 中存在 5-HT 能功能障碍。我们旨在研究早期 PD 中 5-HT 能和多巴胺能活性的相互作用。我们假设 PD 患者存在 5-HT 能和多巴胺能缺陷。我们还假设这些神经递质之间存在相关性,表明 PD 中多巴胺能和 5-HT 能功能之间存在关系。

方法

使用响度依赖听觉诱发电位(LDAEP)检查 9 名未经治疗的 PD 患者在开始左旋多巴治疗前和治疗 12 周后的情况,LDAEP 是中枢 5-HT 能功能的一个很有前途的指标。使用(123)I-FP-CIT 和单光子发射计算机断层扫描(SPECT)收集多巴胺转运蛋白(DAT)。将 LDAEP 值与(123)I-FP-CIT SPECT 数据相关联。

结果

对照组和患者的 LDAEP 存在显著差异(P=0.05),表明 PD 患者的 5-HT 能活性较低。在开始左旋多巴治疗 12 周后,患者和对照组之间的差异消失(P=0.20)。未经治疗的患者中,LDAEP 与 DAT 之间存在相关性的趋势(r=0.65;P=0.057),提示低 5-HT 能活性可能与 PD 中的多巴胺缺乏有关。

结论

我们的结果支持未经治疗的 PD 中 5-HT 能传递减少的假设,并表明低 5-HT 能活性可能与 PD 中的多巴胺病理学有关。这可能与 PD 中高抑郁症患病率有关。

相似文献

1
Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.早期帕金森病中的 5-羟色胺能神经传递:一项评估该疾病中抑郁影响的初步研究。
World J Biol Psychiatry. 2010 Sep;11(6):781-7. doi: 10.3109/15622975.2010.491127.
2
The serotonergic system in Parkinson's disease.帕金森病中的 5-羟色胺能系统。
Prog Neurobiol. 2011 Oct;95(2):163-212. doi: 10.1016/j.pneurobio.2011.08.004. Epub 2011 Aug 22.
3
Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.帕金森病——新型疗法减少左旋多巴治疗问题的机遇
Prog Brain Res. 2008;172:479-94. doi: 10.1016/S0079-6123(08)00923-0.
4
The serotonergic hypothesis for depression in Parkinson's disease: an experimental approach.
Neuropsychopharmacology. 2006 May;31(5):1009-15. doi: 10.1038/sj.npp.1300914.
5
Serotonin and Parkinson's disease: On movement, mood, and madness.血清素与帕金森病:关于运动、情绪及精神错乱
Mov Disord. 2009 Jul 15;24(9):1255-66. doi: 10.1002/mds.22473.
6
Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.用[123I]FP-CIT单光子发射计算机断层扫描成像多巴胺转运体显示,年龄对帕金森病症状阈值无显著影响。
Synapse. 2001 Feb;39(2):101-8. doi: 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1.
7
Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.帕金森病中多巴胺转运体与多巴胺更新率的关系:一项正电子发射断层扫描研究。
Ann Neurol. 2007 Nov;62(5):468-74. doi: 10.1002/ana.21204.
8
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.帕金森病中尾状核与壳核中5-羟色胺标志物的选择性丢失。
Brain. 2008 Jan;131(Pt 1):120-31. doi: 10.1093/brain/awm239. Epub 2007 Oct 22.
9
The dopamine transporter: importance in Parkinson's disease.多巴胺转运体:在帕金森病中的重要性。
Ann Neurol. 2004 Jun;55(6):766-73. doi: 10.1002/ana.20089.
10
Dopamine transporter binding in chronic manganese intoxication.慢性锰中毒中的多巴胺转运体结合
J Neurol. 2003 Nov;250(11):1335-9. doi: 10.1007/s00415-003-0214-1.

引用本文的文献

1
The Loudness Dependence of Auditory Evoked Potentials is associated with the Symptom Severity and Treatment in Boys with Attention Deficit Hyperactivity Disorder.听觉诱发电位的响度依赖性与注意缺陷多动障碍男孩的症状严重程度及治疗相关。
Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):514-525. doi: 10.9758/cpn.2022.20.3.514.
2
Neurophysiological investigation of auditory intensity dependence in patients with Parkinson's disease.帕金森病患者听觉强度依赖性的神经生理学研究。
J Neural Transm (Vienna). 2021 Mar;128(3):345-356. doi: 10.1007/s00702-021-02305-3. Epub 2021 Jan 30.
3
Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease.
前驱期帕金森病中听觉标志物相关性的未来展望
Front Neurol. 2020 Jul 16;11:689. doi: 10.3389/fneur.2020.00689. eCollection 2020.
4
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?帕金森病的突触前多巴胺能终末成像与非运动症状评估:多巴胺能基础的证据?
NPJ Parkinsons Dis. 2017 Jan 25;3:5. doi: 10.1038/s41531-016-0006-9. eCollection 2017.
5
Depressive symptoms in Parkinson's disease and in non-neurological medical illnesses.帕金森病和非神经科医学疾病中的抑郁症状。
Neuropsychiatr Dis Treat. 2013;9:389-96. doi: 10.2147/NDT.S40013. Epub 2013 Mar 21.
6
Response prediction to antidepressants using scalp and source-localized loudness dependence of auditory evoked potential (LDAEP) slopes.使用头皮和声源定位的听觉诱发电位(LDAEP)斜率响度依存度预测抗抑郁药的反应。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:100-7. doi: 10.1016/j.pnpbp.2013.01.012. Epub 2013 Jan 27.
7
Dopaminergic dysregulation, artistic expressiveness, and Parkinson's disease.多巴胺能调节紊乱、艺术表现力与帕金森病
Case Rep Neurol. 2012 Sep;4(3):159-66. doi: 10.1159/000343946. Epub 2012 Nov 3.
8
Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.帕金森病患者的冲动控制障碍:人格和认知状态的作用。
J Neurol. 2012 Nov;259(11):2269-77. doi: 10.1007/s00415-012-6506-6. Epub 2012 Apr 25.
9
Depression in Parkinson disease--epidemiology, mechanisms and management.帕金森病中的抑郁——流行病学、机制与管理。
Nat Rev Neurol. 2011 Dec 26;8(1):35-47. doi: 10.1038/nrneurol.2011.189.
10
Personality traits in patients with Parkinson's disease: assessment and clinical implications.帕金森病患者的人格特征:评估及临床意义。
J Neurol. 2012 Jun;259(6):1029-38. doi: 10.1007/s00415-011-6302-8. Epub 2011 Nov 15.